Arthritis, Rheumatoid: all 2,962 studies
Page 24 of 30. Open to participants first (396), then studies with results posted, then the rest; newest registration first within each.
- A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Early Moderate to Severe Rheumatoid Arthritis Who Completed Study WA19926CompletedNCT01730456Phase 3
- Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With FostamatinibCompletedNCT01725230Phase 1
- Aminopterin Dose Finding Treatment for Methotrexate-Naïve Rheumatoid ArthritisCompletedNCT01724931Phase 2
- Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis PatientStatus unknownNCT01724268Phase 3
- A Study to Validate Questionnaires FLARE and OM-RA-FLARE Measuring Disease Flares in Patients With Rheumatoid Arthritis.CompletedNCT01722617Not applicable
- Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid ArthritisWithdrawnNCT01717846Phase 4
- A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis StudyCompletedNCT01711814Phase 2
- A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RAStatus unknownNCT01709760Phase 3
- Pictorial Representation of Illness and Self MeasureCompletedNCT01707186
- Effect Assessment of Periodontal Prophylaxis on Rheumatoid Arthritis Activity.CompletedNCT01706874
- Pain Evaluation in Rheumatoid ArthritisCompletedNCT01706029
- Dataglove to Measure Joint Stiffness in Patients With ArthritisWithdrawnNCT01705834
- A Nutrition Intervention for Arthritis -2CompletedNCT01700881Not applicable
- Sidus(TM) Post Market Clinical Follow-up (PMCF) StudyCompletedNCT01700543
- Oral Health Assessment in Rheumatoid Arthritis and Other Autoimmune Diseases-- Anti- TNF SubstudyCompletedNCT01698515
- Fatigue in Rheumatoid Arthritis - Longitudinal StudyCompletedNCT01697202
- Description of Joint Population and Assessment of Impact on Health Status of Orencia in Patients With Rheumatoid Arthritis in France. A Database Analysis Based on SFR's ORA Long-term Cohort StudyWithdrawnNCT01694693
- Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily PracticeCompletedNCT01692899
- A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing SpondylitisWithdrawnNCT01692457
- Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean MaleCompletedNCT01688193
- Safety and Effectiveness of Biological DMARDs in Elderly Patients With Rheumatoid ArthritisStatus unknownNCT01685918
- Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)CompletedNCT01685424
- A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With MethotrexateTerminatedNCT01679951Phase 2
- Joint Ultrasound Evaluation of Asymptomatic Rheumatic FeetCompletedNCT01677416
- Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis PatientsCompletedNCT01668641Phase 2
- An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)CompletedNCT01667458
- Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis PatientsCompletedNCT01663116Phase 1/2
- Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging StudyTerminatedNCT01659242Phase 4
- An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid ArthritisCompletedNCT01656278Not applicable
- BIIB057 in Subjects With Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic DrugsWithdrawnNCT01652937Phase 2
- A Study to Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis SubjectsCompletedNCT01649999Phase 2
- A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II)CompletedNCT01649817
- A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid ArthritisCompletedNCT01647451Phase 2
- A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)TerminatedNCT01643863
- Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic TreatmentsStatus unknownNCT01642706
- Analysis of Respiratory Mechanics in Patients With Rheumatoid ArthritisStatus unknownNCT01641705
- Painless Synovitis in Patients With Longstanding Rheumatoid ArthritisStatus unknownNCT01639287
- A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of ActionCompletedNCT01638715Phase 4
- A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MethotrexateTerminatedNCT01636843Phase 2
- A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa BiologicsTerminatedNCT01636817Phase 2
- A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid ArthritisCompletedNCT01636557Phase 1
- Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male VolunteersStatus unknownNCT01635686Phase 1
- Home Based Computer Gaming Hand Exercise Regimen for People With Arthritis Affecting the HandsCompletedNCT01635582Phase 2
- Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis PatientsCompletedNCT01633346
- Rituximab-induced Pulmonary Function ChangesStatus unknownNCT01632124
- A Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of Itacitinib in Subjects With Active Rheumatoid ArthritisCompletedNCT01626573Phase 2
- Effectiveness Registry to Study Therapies for Arthritis and Inflammatory Conditions: The Corrona CERTAIN Sub-studyCompletedNCT01625650
- Disease-Modifying Antirheumatic Drugs Cycle Combination Therapy ResearchStatus unknownNCT01617590Not applicable
- Orofacial Evaluation in Women With Rheumatoid ArthritisCompletedNCT01616641
- An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis PatientsCompletedNCT01615419
- Efficacy and Safety of Tripterygium Wilfordii in Patients With Rheumatoid ArthritisCompletedNCT01613079Phase 2/3
- Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid ArthritisTerminatedNCT01612377Phase 2
- First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid ArthritisCompletedNCT01611688Phase 1
- Doppler Evaluation in RA Patients After Adalimumab.CompletedNCT01609205Phase 4
- Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid ArthritisTerminatedNCT01602302Phase 4
- A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional MedicationsCompletedNCT01600521Not applicable
- A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug TherapyCompletedNCT01597739Phase 2
- Exercise Perceptions and Preferences Among Rheumatoid Arthritis PatientsCompletedNCT01596348
- Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid ArthritisCompletedNCT01593332Phase 4
- Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral SpondyloarthritisCompletedNCT01590966Phase 3
- 24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking MethotrexateCompletedNCT01590459Phase 2
- Optimization of Treatment With Adalimumab (Humira)CompletedNCT01585064
- Study of Different Doses of Folic Acid in Combination With Methotrexate in Rheumatoid ArthritisCompletedNCT01583959Phase 4
- Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip ArthroplastyCompletedNCT01583465Not applicable
- Korean Post-marketing Surveillance for Orencia®CompletedNCT01583244
- Compassionate Use of Pennsaid Topical Lotion (Diclofenac) in Osteo or Rheumatoid ArthritisApproved for marketingNCT01579890
- Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).CompletedNCT01577563
- Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)TerminatedNCT01577264
- An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 3.1CompletedNCT01571219Phase 3
- Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid ArthritisCompletedNCT01567358Phase 1
- Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery DiseaseCompletedNCT01566201Not applicable
- A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid ArthritisCompletedNCT01565655Phase 2
- Safety and Tolerability of NNC0114-0006 at Increasing Dose Levels in Subjects With Rheumatoid ArthritisCompletedNCT01565408Phase 1
- An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)CompletedNCT01565122
- An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Treated With GlucocorticoidsCompletedNCT01564901
- More Added Value of Therapeutic Education in the Management of Patients With Rheumatoid Arthritis (ETP-PR)TerminatedNCT01564147Not applicable
- Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis PatientsTerminatedNCT01559103Phase 1
- TOward the Lowest Effective DOse of Abatacept or TocilizumabCompletedNCT01557374Phase 4
- Real-world Clinical Efficacy of Abatacept in the T3 Data RegistryCompletedNCT01555879
- A Study of Iguratimod in Patients With Active Rheumatoid ArthritisCompletedNCT01554917Phase 4
- A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to MethotrexateCompletedNCT01554696Phase 2
- A Study of the Effect of Supervised Exercise Programme in Patients With Rheumatoid ArthritisCompletedNCT01553305Not applicable
- Safety and Efficacy Vagal Nerve Stimulation in Patients With Rheumatoid ArthritisCompletedNCT01552941Not applicable
- Long Term Extension Study For SPM-005 ParticipantsStatus unknownNCT01552538Phase 1/2
- Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid ArthritisStatus unknownNCT01548001Phase 4
- Safety and Efficacy Study of Umbilical Cord-Derived Mesenchymal Stem Cells for Rheumatoid ArthritisStatus unknownNCT01547091Phase 1/2
- Rheumatoid Foot InsoleStatus unknownNCT01546610Not applicable
- A Nutritional Intervention for ArthritisCompletedNCT01544101Not applicable
- A Prospective, Clinical Investigation of the Vanguard 360 Revision KneeActive, not recruitingNCT01542580
- Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid ArthritisCompletedNCT01534884Phase 1
- The Effects of Cardiac Rehabilitation on Cardiovascular Disease Risk in Rheumatoid Arthritis PatientsCompletedNCT01534871Not applicable
- Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab PegolCompletedNCT01526434
- Patient Rheumatoid Arthritis Social Support StudyTerminatedNCT01525654Not applicable
- Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI)CompletedNCT01519375
- Descriptive Study in Patients Treated With Vimovo™, Including Registration of the Physicians' Prescribing PatternsCompletedNCT01511926
- A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)CompletedNCT01511003Phase 4
- Safety of Zostavax Vaccination in Rheumatoid ArthritisCompletedNCT01506661Phase 1
- Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal SubjectsCompletedNCT01499732
- Benefit of Orthopedic Navigation in the ARThroplasty of the HipCompletedNCT01496300Phase 4
- Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose ReductionStatus unknownNCT01491815Phase 4